医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Oscar Wylee Announces Opening of First 2 Stores in Western Australia

2019年07月08日 PM03:24
このエントリーをはてなブックマークに追加


 

PERTH, Australia

It is with great excitement that Oscar Wylee announces the opening of its first 2 stores in Western Australia. The stores cater to the optometry needs of Perth locals and showcase a range of affordable, high-quality eyewear products.

“From humble beginnings in 2012, Oscar Wylee has grown into a national chain of optometry stores. We are a family run company that looks to the long term with a strong vision of continued growth and dedicated service to our customers,” said Jack Teoh. Bob Teoh and Jack Teoh serve as Oscar Wylee’s co-CEOs . “We welcome you to visit our locations and join our mission to improve the quality of eyewear for all Australians.”

Oscar Wylee prides itself on its philanthropic initiative I CARE FOR EYECARE. For every pair of frames purchased, a portion is donated to someone in need. Oscar Wylee works with established organisations such as Sight For All who are committed to supporting individuals and communities impacted by visual impairment.

Oscar Wylee offers 2 pairs of glasses including standard single vision prescription for $199. Customers can choose from an option of optical frames, non-prescription sunglasses, or a mix of both. Oscar Wylee offers BLUE LIGHT FILTER lenses that block blue light and protect the eyes from digital devices.

Most health fund members may be eligible to claim a rebate on their prescription glasses. Type and level of cover varies in every insurance plan so make sure to check your plan.

Oscar Wylee stores are open nationwide from Monday to Sunday.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190707005072/en/

CONTACT

Oscar Wylee

(02) 8355 4646

info@oscarwylee.com

Ino Tumamao

(02) 8355 4646

pr@oscarwylee.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • 拓臻生物公布其非酒精性脂肪性肝炎(NASH)候选药物-具有肝脏选择性的法尼醇X受体(FXR)激动剂TERN-101-临床Ⅰ期试验安全性和药效学研究结果
  • Terns Pharmaceuticals Announces Safety and Pharmacodynamic Results of a Phase 1 Clinical Trial of TERN-101, a Liver-Selective FXR Agonist in Development for the Treatment of NASH
  • AVITA Medical Half-Year Financial Report for Fiscal 2020
  • 西联汇款启动抗击新型冠状病毒的全球援助项目
  • Jinsan Beverage of Korea Introduces Its 5 Healthy Smoothies for Spring